Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Alpha Tau Medical Ltd ( (DRTS) ) has provided an announcement.
On May 12, 2025, Alpha Tau Medical Ltd. announced the appointment of Nadav Kidron to its Board of Directors following a strategic investment with an affiliate of Oramed Pharmaceuticals Inc. Kidron, who brings extensive experience from his leadership roles in the life sciences sector, is expected to significantly contribute to Alpha Tau’s strategic execution as the company progresses towards the commercialization of its oncology therapeutics.
The most recent analyst rating on (DRTS) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Alpha Tau Medical Ltd stock, see the DRTS Stock Forecast page.
Spark’s Take on DRTS Stock
According to Spark, TipRanks’ AI Analyst, DRTS is a Underperform.
Alpha Tau Medical Ltd is struggling with significant financial challenges, primarily due to a lack of revenue and ongoing cash burn. While technical indicators show a neutral trend, the valuation metrics reflect the company’s unprofitability. The absence of earnings call insights and corporate events limits additional context. Overall, the stock is risky with a low score of 38, suggesting caution for potential investors.
To see Spark’s full report on DRTS stock, click here.
More about Alpha Tau Medical Ltd
Alpha Tau Medical Ltd. is an Israeli oncology therapeutics company founded in 2016, focusing on the research, development, and potential commercialization of Alpha DaRT, an innovative alpha-radiation cancer therapy for the treatment of solid tumors. The technology, designed to deliver highly potent alpha-irradiation directly to tumors while sparing healthy tissue, was initially developed by professors from Tel Aviv University.
Average Trading Volume: 44,896
Technical Sentiment Signal: Buy
Current Market Cap: $249.2M
Find detailed analytics on DRTS stock on TipRanks’ Stock Analysis page.